Purpose To review the outcomes of 23-gauge transconjunctival vitrectomy in patients with postoperative endophthalmitis. Methods Non-randomized, interventional case series of patients with postoperative endophthalmitis over a 1-year period.
Introduction
The advantages of 23-gauge sutureless transconjunctival vitrectomy compared to conventional 20-gauge vitrectomy are shorter surgical [1] [2] [3] and recovery time, 1, 4 and less postoperative discomfort. 1 We reviewed the outcome of 23-gauge transconjunctival vitrectomy in patients with postoperative endophthalmitis.
Case report
Over a 1-year period, vitrectomy was performed on six patients (four acute and two chronic Final visual acuity (VA) was significantly improved compared to preoperative VA (P ¼ 0.026), and was 20/40 or better in 5 of 6 patients (83.3%) overall and 3 of 4 patients (75%) with acute endophthalmitis.
Comment
Our study demonstrates that 23-gauge transconjunctival vitrectomy can be performed safely for both acute and chronic endophthalmitis. Postoperative-wound leak and hypotony have been reported with 25-and 23-gauge transconjunctival vitrectomy systems [1] [2] [3] [4] [5] and may be associated with the removal of peripheral vitreous gel. 1 No patient in our series developed hypotony or subconjunctival bleb formation after surgery.
Increased flexibility of 25-gauge instruments may make complex surgeries more challenging since torsion of the eye is more difficult.
1 With 23-gauge vitrectomy, we were able to indent the eye and clear the vitreous base thoroughly without difficulty.
Visual acuity improved significantly in our patients, with results similar to or better than that reported in reports of elective vitrectomies using 25-gauge systems. [3] [4] [5] The poor VA of patient 3 was due to pre-existing glaucoma and macular pucker.
In conclusion, 23-gauge transconjunctival vitrectomy can be performed safely in patients with postoperative endophthalmitis with no complications or hypotony, and good final VA.
